Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Plos One|December 10, 2016
Central Obesity and H. pylori Infection Influence Risk of Barrett's Esophagus in an Asian PopulationChih-Cheng Chen, Yao-Chun Hsu, Ching-Tai Lee, et al.
Journal of Viral Hepatitis|December 11, 2024
Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus Infection With Interferon or Direct Antiviral TherapyYing-Nan Tsai, Jamie Chieh Lo, Cheng-Hao Tseng, et al.
International Journal of Colorectal Disease|February 4, 2010
An endoscopic training model to improve accuracy of colonic polyp size measurementChi-Yang Chang, Han-Mo Chiu, Hsiu-Po Wang, et al.
Journal of Gastroenterology and Hepatology|April 29, 2025
Increased Prevalence of Barrett's Esophagus in Taiwan: A Prospective Multicenter StudyFu-Jen Lee, Ming-Chang Tsai, Chien-Lin Chen, et al.
Alimentary Pharmacology & Therapeutics|November 20, 2018
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse riskYao-Chun Hsu, Mindie H Nguyen, Lein-Ray Mo, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 2, 2026
Fourteen-day vonoprazan-based dual therapy with amoxicillin as first-line Helicobacter pylori treatment in comparison with sequential therapy: A randomized controlled trialTe-Ling Ma, Chun-Ying Huang, Chen-Ya Kuo, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Impact of amoxicillin resistance on the efficacy of amoxicillin-containing regimens for Helicobacter pylori eradication: analysis of five randomized trialsMei-Jyh Chen, Ming-Shiang Wu, Chien-Chuan Chen, et al.
Journal of Gastroenterology and Hepatology|January 26, 2017
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapyYao-Chun Hsu, Lein-Ray Mo, Chi-Yang Chang, et al.
Pageof 11